Fibrosis in the kidney: Is a problem shared a problem halved?

Fibrogenesis and Tissue Repair

Volumn 5, Issue SUPPL.1, 2012, Pages

  Hewitson, Tim D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; SCAR FORMATION; TISSUE REGENERATION;

EID: 84881005487     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-S1-S14     Document Type: Article

References (30)

1. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007, 117:524-529. 10.1172/JCI31487, 1804380, 17332879.
2. Hakim RM, Lazarus JM. Progression of chronic renal failure. Am J Kidney Dis 1989, 14:396-401.
3. Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009, 296:F1239-F1244. 10.1152/ajprenal.90521.2008, 19144691.
4. Hewitson TD, Darby IA, Bisucci T, Jones CL, Becker GJ. Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. J Am Soc Nephrol 1998, 9:632-642.
5. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007, 257:143-179.
6. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 1992, 41:1134-1142. 10.1038/ki.1992.173, 1351954.
7. Hewitson TD, Becker GJ. Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995, 15:111-117. 10.1159/000168813, 7733146.
8. Quaggin SE, Kapus A. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 2011, 80:41-50. 10.1038/ki.2011.77, 21430641.
9. Bechtel W, McGoohan S, Zeisberg EM, Muller GA, Kalbacher H, Salant DJ, Muller CA, Kalluri R, Zeisberg M. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010, 16:544-550. 10.1038/nm.2135, 3106179, 20418885.
10. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2010, 19:43-50. 10.1097/MNH.0b013e3283328eed, 19779337.
11. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010, 16:535-43. 1p, 10.1038/nm.2144, 20436483.
12. Lam S, Verhagen NAM, Strutz F, Van Der Pijl JW, Daha MR, Van Kooten C. Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1. Kidney Int 2003, 63:878-888. 10.1046/j.1523-1755.2003.00824.x, 12631068.
13. Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 1997, 52:1497-1510. 10.1038/ki.1997.480, 9407495.
14. Kelynack KJ, Hewitson TD, Nicholls KM, Darby IA, Becker GJ. Human renal fibroblast contraction of collagen I lattices is an integrin mediated process. Nephrol Dial Transplant 2000, 15:1766-1772. 10.1093/ndt/15.11.1766, 11071963.
15. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005, 12:353-365. 10.1053/j.ackd.2005.07.011, 16198274.
16. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006, 69:213-217. 10.1038/sj.ki.5000054, 16408108.
17. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 2004, 287:F7-16. 10.1152/ajprenal.00451.2003, 15180923.
18. Zeisberg M, Muller GA, Kalluri R. Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrol Dial Transplant 2004, 19:759-761. 10.1093/ndt/gfh060, 15031324.
19. Garber SL, Mirochnik Y, Brecklin CS, Unemori EN, Singh AK, Slobodskoy L, Grove BH, Arruda JAL, Dunea G. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 2001, 59:876-882. 10.1046/j.1523-1755.2001.059003876.x, 11231342.
20. Samuel CS, Hewitson TD. Relaxin and the progression of kidney disease. Curr Opin Nephrol Hypertens 2009, 18:9-14. 10.1097/MNH.0b013e32831b7096, 19077683.
21. Horl WH. Uremic toxins: new aspects. J Nephrol 2000, 13(Suppl 3):S83-S88.
22. Vanholder R, Glorieux G, Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 2003, 18:463-466. 10.1093/ndt/18.3.463, 12584262.
23. Wessles S, Amann K, Tornig J, Ritz E. Cardiovascular structural changes in uremia: Implications for cardiovascular function. Semin Dial 1999, 12:288-292.
24. Lewy PR, Quintanilla A, Levin NW, Kessler RH. Renal energy metabolism and sodium reabsorption. Annu Rev Med 1973, 24:365-384. 10.1146/annurev.me.24.020173.002053, 4268018.
25. Geigy Scientific Tables 1984, Basle: Ciba-Geigy, Lentner C, 8.
26. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008, 295:F1023-F1029. 10.1152/ajprenal.90209.2008, 18667485.
27. Ruster C, Wolf G. Renin-Angiotensin-Aldosterone System and Progression of Renal Disease. J Am Soc Nephrol 2006, 17:2985-2991. 10.1681/ASN.2006040356, 17035613.
28. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Eng J Med 2001, 345:851-860.
29. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995, 47:1285-1294. 10.1038/ki.1995.183, 7637258.
30. Ihle BU, Becker GJ, Whitworth JA, Charlwood RA, Kincaid-Smith PS. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989, 321:1773-1777. 10.1056/NEJM198912283212601, 2512486.